Orthopedic surgeon to present latest findings on stem cells and plasma rich platelet therapy

Joseph Purita M.D., a well known Orthopedic Surgeon from Florida has announced that plans are being made with the Orthopedic Academies in Sao Paulo Brazil to present his latest findings on the use of stem cells and plasma rich platelet therapy in the treatment of certain bone and joint problems. Dr. Purita is expected to travel in early 2010 to lecture on the effectiveness of these newer types of treatment for osteoarthritis of the hip, knee and shoulder, partial tears of tendons, muscles, and ligaments including rotator cuff tears, and various back conditions including disc herniations.

In a press release dated October 15th 2009 Dr. Purita had reported that 89% of knee patients reported fifty percent relief of all symptoms as well as other data on chronic hip pain successes. Purita wished to retract those findings and report that patients are reporting 85% relief of symptoms across the board for all Stem Cell and Platelet Rich Plasma therapies. The 85% of patients benefiting from these therapies represents results in the good to excellent category. "Our original findings were taken in conjunction with other data from various sources. New data is linked solely to findings for our patients at the Institute for Regenerative and Molecular Orthopedics," Purita reported. "Our patients are faring well with these new types of treatments and our results mirror other organizations providing similar care."

Source:

The Institute for Regenerative and Molecular Orthopaedics

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds no clinically useful biomarkers for long COVID in routine lab tests